Abstract
The B cell-specific transcription factor BACH2 is required for affinity maturation of B cells. Here we show that Bach2-mediated activation of p53 is required for stringent elimination of pre-B cells that failed to productively rearrange immunoglobulin VH-DJH gene segments. After productive VH-DJH gene rearrangement, pre-B cell receptor signaling ends BACH2-mediated negative selection through B cell lymphoma 6 (BCL6)-mediated repression of p53. In patients with pre-B acute lymphoblastic leukemia, the BACH2-mediated checkpoint control is compromised by deletions, rare somatic mutations and loss of its upstream activator, PAX5. Low levels of BACH2 expression in these patients represent a strong independent predictor of poor clinical outcome. In this study, we demonstrate that Bach2(+/+) pre-B cells resist leukemic transformation by Myc through Bach2-dependent upregulation of p53 and do not initiate fatal leukemia in transplant-recipient mice. Chromatin immunoprecipitation sequencing and gene expression analyses carried out by us revealed that BACH2 competes with BCL6 for promoter binding and reverses BCL6-mediated repression of p53 and other cell cycle checkpoint-control genes. These findings identify BACH2 as a crucial mediator of negative selection at the pre-B cell receptor checkpoint and a safeguard against leukemogenesis.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Basic-Leucine Zipper Transcription Factors / genetics
-
Basic-Leucine Zipper Transcription Factors / metabolism*
-
Cell Death
-
Cell Differentiation / genetics
-
Cell Survival / genetics
-
Cell Transformation, Neoplastic / pathology
-
DNA-Binding Proteins / metabolism
-
Gene Deletion
-
Gene Expression Regulation, Leukemic
-
Green Fluorescent Proteins / metabolism
-
Immunoglobulin mu-Chains / metabolism
-
Mice
-
Molecular Sequence Data
-
PAX5 Transcription Factor / metabolism
-
Pre-B Cell Receptors / metabolism*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Precursor Cells, B-Lymphoid / metabolism
-
Precursor Cells, B-Lymphoid / pathology
-
Proto-Oncogene Proteins c-bcl-6
-
Proto-Oncogene Proteins c-myc / metabolism
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
STAT5 Transcription Factor / metabolism
-
Treatment Outcome
-
Tumor Suppressor Protein p53 / metabolism*
-
V(D)J Recombination / genetics
Substances
-
BACH2 protein, human
-
BCL6 protein, human
-
Bach2 protein, mouse
-
Basic-Leucine Zipper Transcription Factors
-
DNA-Binding Proteins
-
Immunoglobulin mu-Chains
-
PAX5 Transcription Factor
-
PAX5 protein, human
-
Pre-B Cell Receptors
-
Proto-Oncogene Proteins c-bcl-6
-
Proto-Oncogene Proteins c-myc
-
RNA, Messenger
-
STAT5 Transcription Factor
-
Tumor Suppressor Protein p53
-
Green Fluorescent Proteins
Associated data
-
GENBANK/HE578163
-
GENBANK/HE578164
-
GENBANK/HE578165
-
GENBANK/HE578166
-
GENBANK/HE578168
-
GENBANK/HE578169
-
GENBANK/HE578170
-
GENBANK/HE578173
-
GENBANK/HE578176
-
GEO/GSE20987
-
GEO/GSE24814
-
GEO/GSE28460
-
GEO/GSE30883
-
GEO/GSE30889
-
GEO/GSE30928
-
GEO/GSE31027
-
GEO/GSE34941
-
GEO/GSE41042
-
GEO/GSE44420